Skip to main content
. 2020 Jul 28;57(4):956–966. doi: 10.3892/ijo.2020.5104

Figure 4.

Figure 4

Suppression of TMEM47 reduces cisplatin chemoresistance of cisplatin-resistant HCC cells. (A) Reverse transcription-PCR analysis of TMEM47 mRNA MHCC97L/CisR-control and MHCC97L/CisR-shTMEM47 cell lines. (B) MTT assay of MHCC97L/CisR-control and MHCC97L/CisR-shTMEM47 cells under cisplatin treatment. (C) Colony formation assay of MHCC97L/CisR-control and MHCC97L/CisR-shTMEM47 cells under cisplatin treatment. (D) In vivo subcutaneous tumor model in nude mice injected with MHCC97L/CisR-control and MHCC97L/CisR-shTMEM47 cells. *P<0.05 and **P<0.01. TMEM47, transmembrane protein 47; HCC, hepatocellular carcinoma; shTMEM47, short hairpin RNA targeting TMEM47.